Neurobiological Technologies (NTII) Stock Statistics & Valuation Metrics

Neurobiological Technologies has a market cap or net worth of $27.00. The enterprise value is ―.

Neurobiological Technologies has 27,020,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Neurobiological Technologies’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Neurobiological Technologies is ―. Neurobiological Technologies’s PEG ratio is ―.

In the last 12 months, Neurobiological Technologies had revenue of ― and earned 3.12M in profits. Earnings per share was ―.

In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.

Neurobiological Technologies pays an annual dividend of $0.05, resulting in a dividend yield of ―

Neurobiological Technologies upcoming earnings date is ―, ―.

Neurobiological Technologies as a current ratio of ―, with Debt / Equity ratio of ―

In the past 12 months, Neurobiological Technologies has paid ― in taxes.

Neurobiological Technologies EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Neurobiological Technologies has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.

Gross margin is ―, with operating margin of ―, and net profit margin of ―.

The average price target for Neurobiological Technologies is ―, which is 11.43% higher than the current price. The consensus rating is ―